• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胃癌各血管及腹腔内滴注多西他赛后血液及腹水中多西他赛浓度的测定]

[Measurement of docetaxel concentration in blood and ascites after drip infusion into each vessel and intraperitoneal cavity of gastric cancer].

作者信息

Naitoh Hiroyuki, Kawaguch Akira, Yamamoto Hiroshi, Mekata Eiji, Tan Tohru, Morii Hiroaki, Chiba Mikio

机构信息

Dept of Surgery, Shiga University of Medical Science.

出版信息

Gan To Kagaku Ryoho. 2004 Nov;31(12):2031-4.

PMID:15570934
Abstract

We measured docetaxel (TXT) concentrations in the blood and ascites after drip infusion into each vessel and intraperitoneal cavity of a patient with advanced gastric cancer. The peak concentration was reached immediately (first time 244 ng/ml, second time 215 ng/ml) after the infusion of TXT (25 mg/m2) into the vessels. The concentration of TXT for ascites peaked after 30 min of drip infusion (first time 26 ng/ml, second time 30 ng/ml). AUC ascites/AUC blood was 27.2% and 35.8% respectively. This is the first report demonstrating the concentration of TXT in ascites after drip infusion into vessels. When TXT was administered into the peritoneal cavity, the peak concentration of ascites was reached immediately (54,200 ng/ml). After 240 min, the TXT concentration in the peritoneal cavity was still high (14,200 ng/ml). In blood, the level peaked (64 ng/ml) at 120 min. After 240 min, the TXT level in the blood remained 44 ng/ml. AUC blood/AUC ascites was only 0.25%. These results suggested that the transition rate of TXT from blood to intraperitoneal cavity was excellent, and that TXT was suitable for the treatment of peritoneal dissemination of gastric cancer. Furthermore, infusion of TXT (25 mg/m2) into the peritoneal cavity may directly and systemically provide its antitumor effect. If we prefer the antitumor effect directly, a much lower dose infusion of TXT may be recommended.

摘要

我们测量了晚期胃癌患者经每条血管及腹腔滴注多西他赛(TXT)后血液和腹水中的多西他赛浓度。向血管内滴注多西他赛(25mg/m²)后,浓度立即达到峰值(第一次244ng/ml,第二次215ng/ml)。向腹水中滴注多西他赛后30分钟,TXT浓度达到峰值(第一次26ng/ml,第二次30ng/ml)。腹水与血液的AUC比值分别为27.2%和35.8%。这是首次报道血管滴注后腹水中TXT的浓度情况。当向腹腔内给药TXT时,腹水的峰值浓度立即达到(54200ng/ml)。240分钟后,腹腔内的TXT浓度仍然很高(14200ng/ml)。血液中,在120分钟时达到峰值(64ng/ml)。240分钟后,血液中的TXT水平仍为44ng/ml。血液与腹水的AUC比值仅为0.25%。这些结果表明,TXT从血液向腹腔的转移率极佳,且TXT适用于治疗胃癌腹膜转移。此外,向腹腔内滴注TXT(25mg/m²)可直接且全身性地发挥其抗肿瘤作用。如果我们更倾向于直接的抗肿瘤作用,可能推荐更低剂量的TXT滴注。

相似文献

1
[Measurement of docetaxel concentration in blood and ascites after drip infusion into each vessel and intraperitoneal cavity of gastric cancer].[胃癌各血管及腹腔内滴注多西他赛后血液及腹水中多西他赛浓度的测定]
Gan To Kagaku Ryoho. 2004 Nov;31(12):2031-4.
2
[A case of advanced gastric cancer treated with weekly paclitaxel with measurement of paclitaxel concentrations in blood and ascites].[1例晚期胃癌采用每周紫杉醇治疗并检测血液和腹水中紫杉醇浓度的病例]
Gan To Kagaku Ryoho. 2003 Oct;30(10):1529-31.
3
[A case of scirrhous carcinoma of the stomach with malignant pleural and peritoneal carcinomatosis responding to the local administration of docetaxel (TXT)].[一例胃硬癌伴恶性胸膜和腹膜转移癌对多西他赛(TXT)局部给药有反应的病例]
Gan To Kagaku Ryoho. 2004 Oct;31(11):1849-51.
4
Pharmacokinetics of docetaxel in gastric cancer patients with malignant ascites.胃癌伴恶性腹水患者多西紫杉醇的药代动力学。
Cancer Chemother Pharmacol. 2013 Mar;71(3):727-31. doi: 10.1007/s00280-012-2066-9. Epub 2013 Jan 12.
5
[Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination].[多西他赛腹腔内给药对胃癌腹膜转移患者的药理研究]
Gan To Kagaku Ryoho. 2002 Oct;29(10):1759-63.
6
Disposition kinetics of taxanes after intraperitoneal administration in rats and influence of surfactant vehicles.紫杉醇在大鼠腹腔注射后的处置动力学及表面活性剂载体的影响。
J Pharm Pharmacol. 2004 May;56(5):629-34. doi: 10.1211/0022357023303.
7
Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.腹腔内多西他赛治疗主要局限于腹腔的晚期恶性肿瘤的I期试验:剂量限制性毒性和药代动力学。
Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5896-901.
8
[A case of gastric cancer with peritoneal recurrence which developed during adjuvant administration of TS-1 showing complete response by weekly docetaxel regimen].
Gan To Kagaku Ryoho. 2005 Jul;32(7):1041-4.
9
[Pharmacological study of weekly docetaxel in patients with metastatic breast cancer].[多西他赛每周给药方案用于转移性乳腺癌患者的药理学研究]
Gan To Kagaku Ryoho. 1999 Sep;26(10):1437-41.
10
Increased antitumor activity in combined treatment TS-1 and docetaxel. A preclinical study using gastric cancer xenografts.
Oncology. 2005;68(2-3):130-7. doi: 10.1159/000086767. Epub 2005 Jul 4.

引用本文的文献

1
Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study.AS 与 SOX 方案作为一线化疗治疗胃癌伴腹膜转移患者的疗效:一项真实世界研究。
BMC Gastroenterol. 2022 Jun 14;22(1):296. doi: 10.1186/s12876-022-02369-9.
2
In vitro cell culture of patient derived malignant pleural and peritoneal effusions for personalised drug screening.对患者来源的恶性胸腔和腹腔积液进行体外细胞培养以进行个性化药物筛选。
J Transl Med. 2020 Apr 10;18(1):163. doi: 10.1186/s12967-020-02331-x.
3
Regional but fatal: Intraperitoneal metastasis in gastric cancer.
局部但致命:胃癌的腹膜转移
World J Gastroenterol. 2016 Sep 7;22(33):7478-85. doi: 10.3748/wjg.v22.i33.7478.
4
Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway.蛋白结合多糖K通过抑制转化生长因子-β信号通路抑制胃癌中的肿瘤纤维化。
Oncol Rep. 2015 Feb;33(2):553-8. doi: 10.3892/or.2014.3636. Epub 2014 Nov 28.
5
Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.一项评估腹腔内多西紫杉醇联合 S-1 治疗腹膜转移胃癌患者的 I/II 期研究。
Cancer Chemother Pharmacol. 2013 May;71(5):1265-72. doi: 10.1007/s00280-013-2122-0. Epub 2013 Feb 20.